Form 4: BIOLIFE SOLUTIONS CHRO Sells Shares for Tax Obligations
Insider Transaction Report
BIOLIFE SOLUTIONS Chief Human Resources Officer, Sarah Aebersold, sold 241 shares of common stock to cover tax withholding obligations.
Summary
- Sarah Aebersold, Chief Human Resources Officer of BIOLIFE SOLUTIONS INC (BLFS), reported a sale of common stock.
- The transaction involved the disposition of 241 shares of common stock at a price of $25.59 per share.
- The sale occurred on January 6, 2026, and was executed pursuant to a Rule 10b5-1(c) trading plan.
- The Rule 10b5-1(c) trading plan was adopted on January 3, 2023, specifically to satisfy tax withholding obligations related to the vesting of restricted stock.
- Following this transaction, Sarah Aebersold beneficially owns 75,765 shares of BIOLIFE SOLUTIONS common stock directly.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine, non-discretionary sale for tax withholding purposes, not indicative of management's view on the company's future prospects.
Positives
- The sale was conducted under a pre-arranged Rule 10b5-1(c) trading plan, indicating a non-discretionary transaction for tax obligations rather than a market timing decision, which enhances transparency and reduces concerns about insider trading.
Negatives
- No specific negatives are identified as this is a routine, non-discretionary transaction for tax purposes.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Management Comments
- The sale reported herein was made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
Industry Context
This insider transaction is a routine, pre-planned event for tax purposes and does not provide specific insights into broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders: Minimal impact as this is a routine, pre-planned sale for tax purposes and does not signal a change in management's confidence or company fundamentals.
Key Dates
| Date | Description |
|---|---|
| 01-03-2023 | Date Rule 10b5-1(c) trading plan was adopted by the reporting person. |
| 01/06/2026 | Date of transaction (sale of common stock). |
| 01/08/2026 | Date the Form 4 was signed by the reporting person. |
Recommendation
holdThe sale by the Chief Human Resources Officer is a pre-planned, non-discretionary transaction to satisfy tax withholding obligations related to restricted stock vesting. It does not reflect a discretionary decision based on the company's future prospects and therefore does not warrant a change in investment recommendation. Investors should 'hold' based on this specific filing, awaiting more substantive operational or financial news.
Keywords
BIOLIFE SOLUTIONS, BLFS, Form 4, Insider Trading, Stock Sale, Tax Withholding, Rule 10b5-1, Sarah Aebersold, CHRO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.